[What is new in symptomatic MS treatment: Part 3-bladder dysfunction].

Henze T, Feneberg W, Flachenecker P, Seidel D, Albrecht H, Starck M, Meuth SG

Open source

DOI
10.1007/s00115-017-0440-x
Published
2018 Feb
Container
Der Nervenarzt
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00115-017-0440-x,
  title = {[What is new in symptomatic MS treatment: Part 3-bladder dysfunction].},
  author = {Henze T and Feneberg W and Flachenecker P and Seidel D and Albrecht H and Starck M and Meuth SG},
  year = {2018},
  journal = {Der Nervenarzt},
  doi = {10.1007/s00115-017-0440-x},
  url = {https://doi.org/10.1007/s00115-017-0440-x}
}

RIS

TY  - JOUR
TI  - [What is new in symptomatic MS treatment: Part 3-bladder dysfunction].
AU  - Henze T
AU  - Feneberg W
AU  - Flachenecker P
AU  - Seidel D
AU  - Albrecht H
AU  - Starck M
AU  - Meuth SG
PY  - 2018
JO  - Der Nervenarzt
DO  - 10.1007/s00115-017-0440-x
UR  - https://doi.org/10.1007/s00115-017-0440-x
ER  - 

APA

T, H., W, F., P, F., D, S., H, A., M, S., & SG, M. (2018). [What is new in symptomatic MS treatment: Part 3-bladder dysfunction].. Der Nervenarzt. https://doi.org/10.1007/s00115-017-0440-x

Source records